10-K Decoder · All companies

Mineralys Therapeutics, Inc.

MLYS · FY2025 · Fiscal year ended Dec 31, 2025 · 10-K filed Mar 2026

Open the dashboardInfographicSummary

FY2025 key figures

$FY2025FY2024Change
Revenue$0K$0K
Operating income−$171M−$192M+11.3%
Net income−$155M−$178M+13.0%

Latest quarter: Q3 2026

Form 10-Q · Three months ended Sep 30, 2026 · filed Nov 4, 2026

$Q3 2026Year earlierChange
Revenue$0K$0K
Operating income−$60.1M−$41.1M−46.2%
Net income−$57.3M−$36.9M−55.3%

Q3 2026 dashboardQ3 2026 infographic

Questions

What was Mineralys's revenue in FY2025?
$0K in FY2025 (Fiscal year ended Dec 31, 2025), no comparable figure vs $0K a year earlier, per its 10-K filed Mar 2026.
Was Mineralys profitable in FY2025?
No: net income was −$155M and operating income −$171M in FY2025.
What was Mineralys's revenue in Q3 2026?
$0K (n/a vs a year earlier), per its Form 10-Q filed Nov 4, 2026.